
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Chong Kun Dang Pharmaceutical"
Count: 283
Selected: 0
NCT ID | Title |
---|
NCT05050604 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients | ||
NCT05041790 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment | ||
NCT06044493 | MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients | ||
NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
NCT05952219 | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 | ||
NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
NCT05928637 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 | ||
NCT05921435 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults | ||
NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
NCT05549401 | Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 | ||
NCT05335044 | Study to Evaluate the Safety and Pharmacokinetics of CKD-331 | ||
NCT05192356 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) | ||
NCT05113693 | Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 | ||
NCT05816759 | Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150 | ||
NCT05881707 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg | ||
NCT05881213 | Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults | ||
NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 | ||
NCT05843162 | A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome | ||
NCT05571813 | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects | ||
NCT05544214 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects | ||
NCT05526742 | A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects | ||
NCT05749861 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) | ||
NCT05741437 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 | ||
NCT05698043 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg | ||
NCT05677438 | A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia | ||
NCT05552495 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions | ||
NCT05540912 | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects | ||
NCT05673369 | Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition | ||
NCT05207761 | Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930 | ||
NCT05657574 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia | ||
NCT05634447 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391 | ||
NCT05274880 | Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 | ||
NCT05526703 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy | ||
NCT05587699 | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | ||
NCT05452525 | Pharmacokinetics and Safety/Tolerability Profile of CKD-379 | ||
NCT05089279 | Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers | ||
NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes | ||
NCT05245084 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg | ||
NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
NCT04673682 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 | ||
NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
NCT04746287 | Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects | ||
NCT04805606 | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 | ||
NCT04488900 | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects | ||
NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
NCT05108038 | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects | ||
NCT05043467 | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus | ||
NCT04869800 | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg |